Does DROSPIRENONE Cause Product dose omission issue? 116 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 116 reports of Product dose omission issue have been filed in association with DROSPIRENONE (Angeliq). This represents 3.5% of all adverse event reports for DROSPIRENONE.
116
Reports of Product dose omission issue with DROSPIRENONE
3.5%
of all DROSPIRENONE reports
0
Deaths
1
Hospitalizations
How Dangerous Is Product dose omission issue From DROSPIRENONE?
Of the 116 reports, 1 (0.9%) required hospitalization.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DROSPIRENONE. However, 116 reports have been filed with the FAERS database.
What Other Side Effects Does DROSPIRENONE Cause?
Intermenstrual bleeding (1,086)
Amenorrhoea (603)
Heavy menstrual bleeding (436)
Dysmenorrhoea (240)
Product use in unapproved indication (154)
Intentional dose omission (123)
Nausea (118)
Headache (117)
Menstruation irregular (117)
Wrong technique in product usage process (95)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which DROSPIRENONE Alternatives Have Lower Product dose omission issue Risk?
DROSPIRENONE vs DROSPIRENONE\ESTETROL
DROSPIRENONE vs DROSPIRENONE\ESTRADIOL
DROSPIRENONE vs DROSPIRENONE\ETHINYL ESTRADIOL
DROSPIRENONE vs DROSPIRENONE\ETHINYL ESTRADIOL\LEVOMEFOLATE
DROSPIRENONE vs DROTAVERINE